Moderna's Covid-19 vaccine shows 93% efficacy through 6 months, as company expects to finish application for approval this month

The efficacy data came from a final analysis of the vaccine's Phase 3 study, which enrolled thousands of participants who received both doses last year, before it was made available to the wider public."In final analysis" of the study,"the Moderna Covid-19 vaccine showed 93% efficacy, with the efficacy remaining durable through six months after administration of the second dose," Moderna said in a news release.

booster," Hoge said."But, we're going to wait for 100-microgram data in the coming weeks to confirm the dose selection of 50 micrograms as the booster before filing." In Thursday's call, Hoge presented early data, yet to be peer reviewed, showing the vaccine's neutralizing antibodies waning six months after the second dose -- including against the Delta variant.

What’s up with Scott Atlas?

Antibodies naturally vane as soon as person stop to encounter a pathogen. Organism immunity is much more complex than just antibodies count and do not need to keep its 'National Guard' deployed all the time, just on response to a pathogen.

So booster every 6 months?

I had Moderna. The second shot was pretty sick for 24 hours but it was worth it

That’s solid considering variants and the time that’s gone by

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Moderna's COVID-19 vaccine 93% effective 6 months after 2nd dose, company saysA booster dose will be necessary prior to the winter season as antibody levels are likely to wane, Moderna said. Effective at giving heart inflammation and infertility. Yay! Get it.
Источник: TODAYshow - 🏆 389. / 55 Прочитайте больше »